Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Weeks 14 0.25 mg Starter dose weekly Weeks 58 0.5 mg Increased weekly Weeks 916 1.0 mg Therapeutic dose Weeks 17+ 2.0 mg Maintenance dose Injection method Subcutaneous (under the skin) Frequency Once per week Provider check-ins Monthly dose adjustments Timeline 20 weeks to full dose What to expect Weight loss milestones and what patients typically experience at each phase
Peyronies disease (CME)
PAE is performed by an interventional radiologist a physician who specializes in using advanced imaging techniques, such as X-rays and ultrasound, to treat conditions from within the body without the need for major surgery
As you eat less, your body draws energy from stored fat reserves
Recent studies highlight how GLP-1 receptor agonistsincluding Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound)exhibit powerful anti-inflammatory effects
You cannot confirm the cold chain was maintained during shipping
